Plasma and tissue oxidative stress index in patients with rheumatic and degenerative heart valve disease.
暂无分享,去创建一个
M. Rabus | O. Erel | C. Yakut | A. Yildiz | Y. Sezen | R. Demirbağ | R. Zeybek | Oğuz Konukoğlu | R. Demi̇rbağ
[1] O. Erel,et al. Influence of oxidative stress on the development of collateral circulation in total coronary occlusions. , 2007, International journal of cardiology.
[2] M. Schafranski,et al. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP). , 2006, International journal of cardiology.
[3] O. Erel,et al. A new automated colorimetric method for measuring total oxidant status. , 2005, Clinical biochemistry.
[4] M. Aksoy,et al. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. , 2005, The Journal of heart valve disease.
[5] M. Mäyränpää,et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. , 2004, Journal of the American College of Cardiology.
[6] G. Aldini,et al. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. , 2004, Archives of biochemistry and biophysics.
[7] O. Erel,et al. A novel automated method to measure total antioxidant response against potent free radical reactions. , 2004, Clinical biochemistry.
[8] A. Çamsarı,et al. Increased levels of high sensitive C‐reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation , 2002, European journal of heart failure.
[9] G. Hanania,et al. [The best of 2001. Valve diseases]. , 2002, Archives des maladies du coeur et des vaisseaux.
[10] Emile R. Mohler,et al. Bone Formation and Inflammation in Cardiac Valves , 2001, Circulation.
[11] L. Mertens,et al. Levels of Circulating Adhesion Molecules in Rheumatic Mitral Stenosis , 2001 .
[12] S. Brener,et al. Factors leading to progression of valvular aortic stenosis. , 1999, The American journal of cardiology.
[13] JanNilsson,et al. Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves , 1999 .
[14] R. Prior,et al. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. , 1998, Clinical chemistry.
[15] L. Ger,et al. The relation between thickened aortic valve and coronary artery disease. , 1997, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.
[16] H. Fan,et al. [Pathological observation and immunohistochemistry study of Type I, III, IV collagen in mitral valve and cardiac interstitium of rheumatic disease]. , 1996, Zhonghua yi xue za zhi.
[17] W. Blackburn,et al. Apolipoprotein A-I decreases neutrophil degranulation and superoxide production. , 1991, Journal of lipid research.
[18] M. Simionescu,et al. Cellular events in the development of valvular atherosclerotic lesions induced by experimental hypercholesterolemia. , 1987, Atherosclerosis.
[19] K. Ingold,et al. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. , 1987, Biochimica et biophysica acta.
[20] W. Aronow,et al. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. , 1987, The American journal of cardiology.